HomeFilePharmacology

Pharmacology

View Category

Antithrombotic Anticoagulants

Does the systematic use of clopidogrel reduce events prior to angioplasty?

Original title: Association of Clopidogrel Pretreatment with mortality, Cardiovascular events, and Major Bleeding among patients undergoing percutaneous coronary...
solaci -
Learn More
Infrapatellar

Cilostazol reduces restenosis in infrapopliteal angioplasty

Original title: Impact of Cilostazol on Angiographic Restenosis after Balloon Angioplasty for Infrapopliteal Artery Disease in Patients with...
solaci -
Learn More
Chronic Ischemic cardiopathy

High-dose atorvastatin for prevention of contrast nephropathy

Original title: Impact of a High Loading Dose of Atorvastatin on Contrast-Induced Acute Kidney Injury. Reference: Quintavalle et al. CIRCULATIONAHA.112.10331,...
solaci -
Learn More
Acute coronary syndromes

To discontinue clopidogrel after a year of infarction can be risky

Reference: Charlot et al. European Heart Journal 2012 (in press).International guideline recommendations approve giving dual antiplatelet therapy...
solaci -
Learn More
Antiplatelet

Percutaneous closure of the appendage: results, evidence, team training.

Our editors talked with Dr. Aníbal Damonte Percutaneous closure of left atrial appendage is now a practice that...
solaci -
Learn More
Antithrombotic Anticoagulants

In patients with stroke history, Ticagrelor is superior to Clopidogrel

James SK, Storey RF, Khurmi N, et al. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes...
solaci -
Learn More
Antithrombotic Anticoagulants

Six Months Sufficient for Dual Antiplatelet Therapy

Reference: Kandzari DE, Barrer CS, Leon MB, et al. Dual antiplatelet therapy duration and clinical outcomes following treatment...
solaci -
Learn More
Acute coronary syndromes

Ticagrelor vs. Clopidogrel in ST elevation MI: Pros and cons

Platelet Inhibition in the PLATO study: insights from the ECG substudy. En el Estudio PLATO quedó evidenciado que...
solaci -
Learn More